Viewing Study NCT02879760

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2026-07-01 @ 3:40 AM
Study NCT ID: NCT02879760
Status: COMPLETED
Last Update Posted: 2020-10-06
First Post: 2016-08-15
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer Patients
Sponsor: Turnstone Biologics, Corp.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lung View
None Cancer View
None Chemotherapy View
None Oncolytic virus View
None Immunotherapy View
None Pembrolizumab View
None Keytruda View